Efficacy, cost-utility and reach of an eHealth self-management application 'Oncokompas' that helps cancer survivors to obtain optimal supportive care

Autor: Veerle M.H. Coupé, C. René Leemans, Cornelia F. van Uden-Kraan, Birgit I. Witte, Irma M. Verdonck-de Leeuw, Femke Jansen, Pim Cuijpers, Lonneke V. van de Poll-Franse, Anja van der Hout
Přispěvatelé: Medical and Clinical Psychology, Otolaryngology / Head & Neck Surgery, Epidemiology and Data Science, CCA - Cancer Treatment and quality of life, AGEM - Re-generation and cancer of the digestive system, APH - Personalized Medicine, APH - Mental Health, APH - Methodology, Clinical Psychology, Stochastics, APH - Global Health
Jazyk: angličtina
Rok vydání: 2017
Předmět:
Male
Health Knowledge
Attitudes
Practice
Time Factors
Cost-Benefit Analysis
Cancer survivors
Health Behavior
Medicine (miscellaneous)
law.invention
Study Protocol
0302 clinical medicine
Clinical Protocols
Randomized controlled trial
law
Neoplasms
Adaptation
Psychological
Supportive Care Study
Pharmacology (medical)
030212 general & internal medicine
Netherlands
lcsh:R5-920
Self-management
Patient activation
Health Care Costs
Self Efficacy
Telemedicine
3. Good health
Research Design
030220 oncology & carcinogenesis
Female
Quality-Adjusted Life Years
lcsh:Medicine (General)
medicine.medical_specialty
Context (language use)
03 medical and health sciences
Quality of life (healthcare)
SDG 3 - Good Health and Well-being
medicine
eHealth
Humans
Cancer survivors
eHealth application
Self-management
Patient activation
Supportive care
Physician-Patient Relations
business.industry
eHealth application
Head and neck cancer
Cancer
medicine.disease
Self Care
Physical therapy
Patient Participation
business
Supportive care
Zdroj: Trials, 18(1):228. BioMed Central
Trials, Vol 18, Iss 1, Pp 1-11 (2017)
van der Hout, A, van Uden-Kraan, C F, Witte, B I, Coupé, V M H, Jansen, F, Leemans, C R, Cuijpers, P, van de Poll-Franse, L V & Verdonck-de Leeuw, I M 2017, ' Efficacy, cost-utility and reach of an eHealth self-management application 'Oncokompas' that helps cancer survivors to obtain optimal supportive care : Study protocol for a randomised controlled trial ', Trials, vol. 18, no. 1, 228 . https://doi.org/10.1186/s13063-017-1952-1
Trials
van der Hout, A, van Uden-Kraan, C F, Witte, B I, Coupé, V M H, Jansen, F, Leemans, C R, Cuijpers, P, van de Poll-Franse, L V & Verdonck-de Leeuw, I M 2017, ' Efficacy, cost-utility and reach of an eHealth self-management application 'Oncokompas' that helps cancer survivors to obtain optimal supportive care: study protocol for a randomised controlled trial ', Trials, vol. 18, no. 228, 228, pp. 1-11 . https://doi.org/10.1186/s13063-017-1952-1
Trials, 18(228):228, 1-11. BioMed Central
ISSN: 1745-6215
Popis: Background Cancer survivors have to deal with a wide range of physical symptoms, psychological, social and existential concerns, and lifestyle issues related to cancer and its treatment. Therefore, it is essential that they have access to optimal supportive care services. The eHealth self-management application Oncokompas was developed to support cancer survivors with where they need to turn to for advice and guidance, as well as to increase their knowledge on the availability of optimal support. A randomised controlled trial will be conducted to assess the efficacy, cost-utility and reach of Oncokompas as an eHealth self-management application compared with care as usual among cancer survivors. Methods/design Adult cancer survivors diagnosed with breast, colorectal or head and neck cancer or lymphoma who are at 3 months to 5 years since curative treatment will be included. In total, 544 cancer survivors will be randomly assigned to the intervention group or a wait-list control group. The primary outcome measure is patient activation. Secondary outcome measures include self-efficacy, personal control, perceived patient-physician interaction, need for supportive care, mental adjustment to cancer and health-related quality of life. Furthermore, cost-utility outcomes will be assessed. Reach is defined as the percentage of cancer survivors who get access to Oncokompas within the context of this trial. Questionnaires will be administered at baseline, post-intervention and at 3- and 6-month follow-up. Discussion In this study, we will evaluate the efficacy and cost-utility of Oncokompas among cancer survivors, as well as the reach of Oncokompas. These are essential first steps in the translation of research into practice and contribute to sustainable adoption, implementation and maintenance of an evidence-based Oncokompas. Trial registration Netherlands Trial Register identifier: NTR5774. Registered on 8 March 2016. Electronic supplementary material The online version of this article (doi:10.1186/s13063-017-1952-1) contains supplementary material, which is available to authorized users.
Databáze: OpenAIRE
Externí odkaz: